BRIEF--Adocia and Lilly announce positive results from Phase 1b study of Lispro U100
April 27, 2016 at 12:28 PM EDT
* Adocia and Lilly announce positive results from a Phase 1b study of repeated administration of ultra-rapid biochaperone Lispro U100 in people with type 2 diabetes Source text for Eikon: Further company coverage: (Gdynia Newsroom)